CoChat

To buy or not to buy—evaluating commercial AI solutions in radiology (the ECLAIR guidelines)

Open access
Omoumi, Patrick, Ducarouge, Alexis, Tournier, Antoine, Harvey, Hugh, Kahn, Charles E., Louvet-de Verchère, Fanny, Pinto Dos Santos, Daniel, Kober, Tobias, Richiardi, Jonas · 2021 · European Radiology
Cited by 167

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Artificial intelligence (AI) has made impressive progress over the past few years, including many applications in medical imaging. Numerous commercial solutions based on AI techniques are now available for sale, forcing radiology practices to learn how to properly assess these tools. While several guidelines describing good practices for conducting and reporting AI-based research in medicine and radiology have been published, fewer efforts have focused on recommendations addressing the key questions to consider when critically assessing AI solutions before purchase. Commercial AI solutions are typically complicated software products, for the evaluation of which many factors are to be considered. In this work, authors from academia and industry have joined efforts to propose a practical framework that will help stakeholders evaluate commercial AI solutions in radiology (the ECLAIR guidelines) and reach an informed decision. Topics to consider in the evaluation include the relevance of the solution from the point of view of each stakeholder, issues regarding performance and validation, usability and integration, regulatory and legal aspects, and financial and support services. Key Points: • Numerous commercial solutions based on artificial intelligence techniques are now available for sale, and radiology practices have to learn how to properly assess these tools. • We propose a framework focusing on practical points to consider when assessing an AI solution in medical imaging, allowing all stakeholders to conduct relevant discussions with manufacturers and reach an informed decision as to whether to purchase an AI commercial solution for imaging applications. • Topics to consider in the evaluation include the relevance of the solution from the point of view of each stakeholder, issues regarding performance and validation, usability and integration, regulatory and legal aspects, and financial and support services.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00330-020-07684-x

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 167

Metadata

Authors
Omoumi, P., Ducarouge, A., Tournier, A., Harvey, H., Kahn, C. E., Louvet-de Verchère, F., Pinto Dos Santos, D., Kober, T., & Richiardi, J.
Venue
European Radiology
Published
2021-03-05
Volume
31
Issue
6
Pages
3786-3796
ISSN
  • 0938-7994 (ISSN-L)
  • 1432-1084
OpenAlex
W3134020135
Cited by
167
References
12
FWCI
7.14
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: To buy or not to buy—evaluating commercial AI solutions in radiology (the ECLAIR guidelines). https://app.cochat.ai/papers/10.1007/s00330-020-07684-x
The paper
Omoumi, P., Ducarouge, A., Tournier, A., Harvey, H., Kahn, C. E., Louvet-de Verchère, F., Pinto Dos Santos, D., Kober, T., & Richiardi, J. (2021). To buy or not to buy—evaluating commercial AI solutions in radiology (the ECLAIR guidelines). European Radiology. https://doi.org/10.1007/s00330-020-07684-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.